ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2%

Fri, 1 Nov

ALEMBIC PHARMA has announced its results for the quarter ended September 2019. Here is a detailed performance review of the same:

ALEMBIC PHARMA Quarterly Financials

Year-on-Year Performance:

• The company's operating income during the quarter grew 10.1% on a year-on-year (YoY) basis. The expenses were up by 8.6% YoY during the same period.
• The company's operating profit increased by 14.3% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 27.8% in 2QFY20 as against 26.8% in 2QFY19.
• Depreciation charges increased by 25.6% and finance costs increased by 21.8% YoY, respectively.
• Other income declined by 84.8% YoY during the quarter.
• Net profit for the quarter increased by 25.2% YoY. Net profit margins during the quarter increased from 17.7% in 2QFY19 to 20.2% in 2QFY20.

Quarter-on-Quarter Performance:

• The company's operating income during the quarter grew 30.8% on a quarter-on-quarter (QoQ) basis. The expenses were up by 23.7% QoQ during the same period.
• The company's operating profit increased by 76.0% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 27.8% in 2QFY20 as against 20.7% in 1QFY19.
• Net profit for the quarter increased by 103.0% QoQ, while net profit margins increased from 12.9% in 1QFY19 to 20.2% in 2QFY20.

To see how ALEMBIC PHARMA has performed over the last eight quarters,please visit here.

Free Guide: Find the Next Crorepati Stock in this Futuristic Industry

ALEMBIC PHARMA Share Price Performance

Over the last one year,ALEMBIC PHARMA share price has moved down from Rs 601.6 to Rs 561.0, registering a Loss of Rs 40.6 or around 6.7%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,342.2 (up 0.9%). Over the last one year it has moved down from 14,632.9 to 13,342.2, a gain of 1,291 points (down 8.8%).

Overall, the S&P BSE SENSEX is up 16.6% over the year.

Current Valuations

At the current price of Rs 561.0, the price to earnings (P/E) ratio of ALEMBIC PHARMA stands at 15.6 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 3.9 times.